Outcomes in Pancreatic Cancer Surgery

Surgical Clinics of North America

Volumn 90, Issue 2, 2010, Pages 219-234

  Orr, Richard K ^a,b  

^a Gibbs Cancer Center   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Complications; Mortality; Outcomes; Pancreatic cancer

Indexed keywords

CANCER INCIDENCE; CANCER SURGERY; CLINICAL TRIAL; HUMAN; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS RESECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURGEON; SURGICAL MORTALITY;

ADENOCARCINOMA; HUMANS; LAPAROSCOPY; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 77950804445     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2009.12.007     Document Type: Review

References (103)

1. McPhee J.T., Hill J.S., Whalen G.F., et al. Perioperative mortality for pancreatectomy-a national perspective. Ann Surg 2007, 246:246-253.
2. Whipple A.O., Pasons W.B., Mullins C.R. Treatment of cancer of the ampulla of Vater. Am Surg 1935, 102:763-779.
3. Cameron J.L., Pitt H.A., Yeo C.J., et al. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993, 217:430-438.
4. Traverso L.W. The state of the highest level of evidence: an overview of systematic reviews of pancreatobiliary disease customized for the gastroenterologist and GI surgeon. J Gastrointest Surg 2008, 12:617-619.
5. Russell T.R. Discussion of Gasper WJ, et al. Ann Surg 2009, 25:483.
6. Lamont E.B., Hayreh D., Pickett K.E., et al. Is patient travel distance associated with survival on phase II clinical trials in oncology?. J Natl Cancer Inst 2003, 95:1370-1375.
7. Ballard D.J., Bryant S.C., O'Brien P.C., et al. Referral selection bias in the Medicare hospital mortality prediction model: are centers of referral for Medicare beneficiaries necessarily centers of excellence?. Health Serv Res 1994, 28:771-784.
8. Bilimoria K.Y., Bentrem D.J., Feinglass J.M., et al. Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol 2008, 26:4626-4633.
9. Kang C.M., Kim D.H., Choi G.H., et al. Detrimental effect of postoperative complications on oncologic efficacy of R0 pancreatectomy in ductal adenocarcinoma of the pancreas. J Gastrointest Surg 2009, 13:907-914.
10. Howard T.J., Krug J.E., Yu J., et al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 2006, 10:1338-1345.
11. Crile G. The advantages of bypass operations over radical pancreaticoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 1970, 130:1049-1053.
12. Brooks J.R., Culebras J.M. Cancer of the pancreas. Palliative operation, Whipple procedure, or total pancreatectomy?. Am J Surg 1976, 131:516-520.
13. Wakeman C.J., Martin I.G., Robertson R.W., et al. Pancreatic cancer: management and survival. ANZ J Surg 2004, 74:941-944.
14. Gudjonsson B. Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg 1995, 181:483-503.
15. Conlon K.C., Klimstra D.S., Brennan M.F. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996, 223:273-279.
16. Cleary S.P., Gryfe R., Guindi M., et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 2004, 198:722-731.
17. Yeo C.J., Sohn T.A., Cameron J.L., et al. Periampullary carcinoma - analysis of 5-year survivors. Ann Surg 1998, 227:821-831.
18. Schnelldorfer T., Ware A.L., Sarr M.G., et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?. Ann Surg 2008, 247:456-462.
19. Garcea G., Dennison A.R., Pattenden C.J., et al. Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP 2008, 9:99-132.
20. Riediger H., Keck T., Wellner U., et al. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 2009, 13:1337-1344.
21. Westgaard A., Tafjord S., Farstad I.N., et al. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal margin is an independent prognostic factor. BMC Cancer 2008, 8:5.
22. Strasberg S.M., Linehan D.C., Hawkins W.G. Radical antegrade pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins. J Am Coll Surg 2007, 204:244-249.
23. Barugola G., Partelli S., Marcucci S., et al. Resectable pancreatic cancer: who really benefits from resection?. Ann Surg Oncol 2009, 10.1245/s10434-009-0670-7.
24. Winter J.M., Cameron J.L., Yeo C.J., et al. Biochemical markers predict morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 2007, 204:1029-1038.
25. Pratt W., Joseph S., Callery M.P., et al. POSSUM accurately predicts morbidity for pancreatic resection. Surgery 2008, 143:8-19.
26. Copeland G.P., Jones D., Walters M. POSSUM: a scoring system for the surgical audit. Br J Surg 1991, 78:356-360.
27. De Castro S.M., Houwert J.T., Lagarde S.M., et al. Evaluation of POSSUM for patients undergoing pancreatoduodenectomy. World J Surg 2009, 33:1481-1487.
28. Khan A.W., Shah S.R., Agarwal A.K., et al. Evaluation of the POSSUM scoring system for comparative audit in pancreatic surgery. Dig Surg 2003, 20:539-545.
29. Warshaw A.L., Tepper J.E., Shipley W.U. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg 1986, 151:76-80.
30. Ellsmere J., Mortele K., Sahani D., et al. Does multidetector-row CT eliminate the role of diagnostic laparoscopy in assessing resectability of pancreatic head adenocarcinoma?. Surg Endosc 2005, 19:369-373.
31. Ernestvedt C.K., Mayo S.C., Diggs B.S., et al. Diagnostic laparoscopy for patients with potentially resectable pancreatic carcinoma: is it cost-effective in the current era?. J Gastrointest Surg 2008, 12:1177-1184.
32. Mayo S.C., Austin D.F., Sheppard B.C., et al. Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era?. J Am Coll Surg 2009, 208:87-95.
33. Shah D., Fisher W.E., Hodges S.E., et al. Preoperative prediction of complete resection in pancreatic cancer. J Surg Res 2008, 147:216-220.
34. Maithel S.K., Maloney S., Winston C., et al. Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinomas. Ann Surg Oncol 2008, 15:3512-3520.
35. Bradley E.L. Pancreatoduodenectomy for pancreatic adenocarcinoma. Triumph, triumphalism, or transition?. Arch Surg 2002, 137:771-773.
36. Reddy S., Wolfgang C.L., Cameron J.L., et al. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival. Ann Surg 2009, 250:282-287.
37. Nathan H., Wolfgang C.L., Edil B.H., et al. Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective. J Surg Oncol 2009, 99:87-92.
38. Schmidt C.M., Glant J., Winter J.M., et al. Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery 2007, 142:572-580.
39. Hernandez J., Mullinax J., Clark W., et al. Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins. Ann Surg 2009, 250:76-80.
40. Pedrazzoli S., DiCarlo V., Dionigi R., et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized trial. Ann Surg 1998, 228:508-517.
41. Farnell M.B., Pearson R.K., Sarr M.G., et al. A prospective randomized trail comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005, 138:618-628.
42. Riall T.S., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma - part 3: update on 5-year survival. J Gastrointest Surg 2005, 9:1191-1204.
43. Farnell M.B., Aranha G.V., Nimura Y., et al. The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence. J Gastrointest Surg 2008, 12:651-656.
44. Fortner J.G. Regional resection of cancer of the pancreas: a new surgical approach. Surgery 1973, 73:307-320.
45. Fortner J.G., Fortner J.G., Kim D.K., et al. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg 1977, 186(1):42-50.
46. Ramacciato G., Mercantini P., Petrucciani N., et al. Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma?. Ann Surg Oncol 2009, 16:817-825.
47. Martin R.C.G., Scoggins C.R., Egnatashvili V., et al. Arterial and venous reconstruction for pancreatic adenocarcinoma: operative and long-term outcomes. Arch Surg 2009, 144:154-159.
48. Adham M., Mirza D.F., Chapui F., et al. Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors. HPB (Oxford) 2006, 8:465-473.
49. Sugiura Y., Horio T., Aiko S., et al. Pancreatectomy for pancreatic cancer with reference to combined resection of the vessels, twenty nine year experience by a single surgeon. Keio J Med 2009, 58:103-109.
50. Siriwardana H.P., Siriwardena A.K. Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 2006, 93:662-673.
51. Stojadinovic A., Brooks A., Hoos A., et al. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg 2003, 196:954-964.
52. Karanicolas P.J., Davies E., Kunz R., et al. The pylorus: take it or leave it? Systematic review and meta-analysis of pylorus-preserving versus standard Whipple pancreaticoduodenectomy for pancreatic or periampullary cancer. Ann Surg Oncol 2007, 14:1825-1834.
53. Diener M.K., Knaebel H.P., Heukaufer C., et al. A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg 2007, 245:187-200.
54. Huang J.J., Yeo C.J., Sohn T.A., et al. Quality of life after pancreaticoduodenectomy. Ann Surg 2000, 231:890-898.
55. Crippa S., Dominguez I., Rodriguez J.R., et al. Quality of life in pancreatic cancer: analysis by stage and treatment. J Gastrointest Surg 2008, 12:783-794.
56. Trede M. Invited critique. Arch Surg 2002, 137:773.
57. Vento P., Mustonen H., Joensuu T., et al. Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer. World J Gastroenterol 2007, 13:2945-2951.
58. Morganti A.G., Massaccesi M., La Torre G., et al. A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. Ann Surg Oncol 2009, 10.1245/s10434-009-0762-4.
59. Winter J.M., Cameron J.L., Campbell K.A., et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest surg 2006, 10:1199-1210.
60. Grobmyer S.R., Pieracci F.M., Allen P.J., et al. Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J Am Coll Surg 2007, 204:356-364.
61. Pratt W.B., Vollmer C.M., Callery M.P. Outcomes in pancreatic surgery are negatively influenced by pre-operative hospitalization. HPB (Oxford) 2009, 11:57-65.
62. Kazanjian K.K., Hines O.J., Duffy J.P., et al. Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss. Arch Surg 2008, 143:1166-1171.
63. Fernandez-del-Castillo C., Rattner D.W., Warshaw A.L. Standards for pancreatic resection in the 1990s. Arch Surg 1995, 130:295-300.
64. Simons J.P., Shah S.A., Ng S.C., et al. National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg 2009, 13:1798-1805.
65. Reddy D.M., Townsend C.M., Kuo Y., et al. Readmission after pancreatectomy for pancreatic cancer in Medicare patients. J Gastrointest Surg 2009, 13:1963-1975.
66. DeOliveira M.L., Winter J.M., Shafer M., et al. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 2006, 244:931-939.
67. Clavien P.A., Sanabria J.R., Strasberg S.M. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 1992, 111:518-526.
68. Rodriguez J.B., Soto Germes S., Pandharipande P.V., et al. Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg 2006, 141:361-366.
69. Schmidt C.M., Choi J., Powell E.S., et al. Pancreatic fistula following pancreaticoduodenectomy: clinical predictors and patient outcomes. HPB Surg 2009, 2009:404520.
70. Adams D.B. The pancreatic anastomosis: the danger of a leak, which anastomotic technique is better?. J Gastrointest Surg 2009, 13:1182-1183.
71. Luft H.S., Bunker J.P., Enthoven A.C. Should operations be regionalized? The empirical relationship between surgical volume and mortality. N Engl J Med 1979, 301:1364-1369.
72. Vollmer C.M., Pratt W., Vanounou T., et al. Quality assessment in high-acuity surgery - volume and mortality are not enough. Arch Surg 2007, 142:371-380.
73. Joseph B., Morton J.M., Hernandez-Boussard T., et al. Relationship between hospital volume, system clinical resources, and mortality in pancreatic resection. J Am Coll Surg 2009, 208:520-527.
74. Halm E.A., Lee C., Chassin M.R. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 2002, 137:511-520.
75. Ihse I. The volume-outcome relationship in cancer surgery: a hard sell. Ann Surg 2003, 238:777-781.
76. Khuri S.F., Henderson W.G. The case against volume as a measure of quality in surgical care. World J Surg 2005, 29:1222-1229.
77. Leapfrog Group Website Available at:, Accessed November 1, 2009. http://www.leapfroggroup.org/home.
78. Birkmeyer J.D., Siwers A.E., Finlayson E.V.A., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002, 346:1128-1137.
79. Birkmeyer J.D., Stukel T.A., Siewers A.E., et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003, 349:2117-2127.
80. Eppsteiner R.W., Csikesz N.G., McPhee J.T., et al. Surgeon volume impacts hospital mortality for pancreatic resection. Ann Surg 2009, 249:635-640.
81. Nathan H., Cameron J.L., Choti M.A., et al. The volume-outcome effect in hepato-pancreato-biliary surgery: hospital versus surgeon contributions and the specificity of the relationship. J Am Coll Surg 2009, 208:528-538.
82. Parks R.W., Bettschart V., Frame S., et al. Benefits of subspecialisation in the management of pancreatic cancer: results of a Scottish population-based study. Br J Cancer 2004, 91:459-465.
83. Csikesz N.C., Simons J.P., Tseng J.F., et al. Surgical specialization and operative mortality in hepato-pancreatico-biliary (HPB) surgery. J Gastrointest surg 2008, 12:1534-1539.
84. Tseng J.F., Pisters P.W.T., Lee J.E., et al. The learning curve in pancreatic surgery. Surgery 2007, 141:694-701.
85. Birkmeyer J.D., Warshae L.W., Finlayson S.R.G., et al. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 1999, 126:178-183.
86. Dimick J.B., Welch H.G. The zero mortality paradox in surgery. J Am Coll Surg 2008, 206:13-16.
87. Schell M.T., Barcia A., Spitzer A.L., et al. Pancreaticoduodenectomy: volume is not associated with outcome within an academic health care system. HPB Surg 2008, 2008:825940.
88. Mukhtar R.A., Kattan O.M., Harris H.W. Variation in annual volume at a university hospital does not predict mortality for pancreatic resections. HPB Surg 2008, 2008:190914.
89. Birkmeyer J.D., Dimick J.B. Potential benefits of the new Leapfrog standards: effect of process and outcome measures. Surgery 2004, 135:569-575.
90. Lwin A.K., Shepard D.S. Estimating lives saved from universal adoption of the Leapfrog safety and quality standards: 2008 update Available at:, Accessed November 9, 2009. http://www.leapfroggroup.org/about_us/how_and_why.
91. Shahian D.M., Normand S.T. The volume-outcome relationship: from Luft to Leapfrog. Ann Thorac Surg 2003, 75:1048-1058.
92. Cunningham J.D., O'Donnell N., Starker P. Surgical outcomes following pancreatic resection at a low-volume community hospital: do all patients need to be sent to a regional cancer center?. Am J Surg 2009, 198:227-230.
93. Gasper W.J., Glidden D.V., Chengshi J., et al. Has recognition of the relationship between mortality rates and hospital volume for major cancer surgery in California made a difference? A follow-up analysis of another decade. Ann Surg 2009, 25:472-483.
94. Murphy M.M., Knaus W.J., Ng SC., et al. Total pancreatectomy: a national study. HPB (Oxford) 2009, 11:476-482.
95. Rosemurgy A., Cowgill S., Coe B., et al. Frequency with which surgeons undertake pancreaticoduodenectomy continues to determine length of stay, hospital charges, and in-hospital mortality. J Gastrointest Surg 2008, 12:442-449.
96. Van Heek N.T., Kuhlmann K.F.D., Scholten R.J., et al. Hospital volume and mortality after pancreatic resection. A systematic review and an evaluation of intervention in the Netherlands. Ann Surg 2005, 242:781-790.
97. Ghaferi A.A., Birkmeyer J.D., Dimick J.B. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 2009, 361:1368-1375.
98. Jacobs D.O. Variation in hospital mortality associated with inpatient surgery - an S.O.S. N Engl J Med 2009, 361:1398-1399.
99. Lemmens L., van Zelm R., Borel Rinkes I., et al. Clinical and organizational content of clinical pathways for digestive surgery: a systematic review. Dig Surg 2009, 26:91-99.
100. Porter G.A., Pisters P.W., Mansyur C., et al. Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. Ann Surg Oncol 2000, 7:484-489.
101. Kennedy E.P., Rosato E.L., Sauter P.K., et al. Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution - the first step in multidisciplinary team building. J Am Coll Surg 2007, 204:917-923.
102. Kennedy E.P., Grenda T.R., Sauter P.K., et al. Implementation of a critical pathway for distal pancreatectomy at an academic institution. J Gastrointest Surg 2009, 13:938-944.
103. Maa J., Gosnell J.E., Gibbs V.C., et al. Exporting excellence for Whipple resection to refine the Leapfrog initiative. J Surg Res 2007, 138:189-207.